Wells Fargo & Company Spdr Ser Tr Spdr S&P Pharmaceu Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Wells Fargo & Company holds 89,464 shares of XPH stock, worth $3.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,464

Previous 86,331 3.63%

Holding current value

$3.86 Million

Previous $3.71 Million 5.58%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$42.3 - $45.81 $132,525 - $143,522	3,133 Added 3.63%	89,464 $3.92 Million
Q4 2024 Feb 12, 2025	BUY	$42.71 - $48.29 $736,064 - $832,229	17,234 Added 24.94%	86,331 $3.71 Million
Q3 2024 Nov 13, 2024	SELL	$39.24 - $45.31 $121,604 - $140,415	-3,099 Reduced 4.29%	69,097 $3.07 Million
Q2 2024 Aug 13, 2024	BUY	$39.09 - $42.64 $168,790 - $184,119	4,318 Added 6.36%	72,196 $2.87 Million
Q1 2024 May 10, 2024	SELL	$41.38 - $45.49 $3.88 Million - $4.27 Million	-93,819 Reduced 58.02%	67,878 $2.93 Million
Q4 2023 Feb 09, 2024	BUY	$35.2 - $41.92 $2.66 Million - $3.16 Million	75,465 Added 87.51%	161,697 $6.73 Million
Q3 2023 Nov 13, 2023	BUY	$39.75 - $44.12 $1.53 Million - $1.7 Million	38,459 Added 80.5%	86,232 $3.43 Million
Q2 2023 Aug 15, 2023	SELL	$39.1 - $42.57 $59,823 - $65,132	-1,530 Reduced 3.1%	47,773 $1.96 Million
Q1 2023 May 12, 2023	SELL	$39.61 - $44.25 $1.33 Million - $1.48 Million	-33,458 Reduced 40.43%	49,303 $2.02 Million
Q4 2022 Feb 13, 2023	BUY	$40.06 - $43.59 $764,785 - $832,176	19,091 Added 29.98%	82,761 $3.39 Million
Q3 2022 Nov 14, 2022	BUY	$39.59 - $44.52 $736,651 - $828,383	18,607 Added 41.29%	63,670 $2.56 Million
Q2 2022 Aug 12, 2022	BUY	$38.15 - $46.44 $204,255 - $248,639	5,354 Added 13.48%	45,063 $1.89 Million
Q1 2022 May 16, 2022	SELL	$41.55 - $46.61 $116,838 - $131,067	-2,812 Reduced 6.61%	39,709 $1.8 Million
Q4 2021 Feb 14, 2022	SELL	$43.72 - $52.45 $70,083 - $84,077	-1,603 Reduced 3.63%	42,521 $1.96 Million
Q3 2021 Nov 15, 2021	SELL	$46.51 - $53.1 $85,578 - $97,704	-1,840 Reduced 4.0%	44,124 $2.09 Million
Q2 2021 Aug 16, 2021	SELL	$48.16 - $53.09 $119,966 - $132,247	-2,491 Reduced 5.14%	45,964 $2.38 Million
Q1 2021 May 13, 2021	BUY	$49.44 - $56.01 $41,035 - $46,488	830 Added 1.74%	48,455 $2.44 Million
Q4 2020 Feb 09, 2021	SELL	$43.42 - $52.06 $961,970 - $1.15 Million	-22,155 Reduced 31.75%	47,625 $2.48 Million
Q3 2020 Nov 05, 2020	BUY	$42.46 - $45.34 $551,258 - $588,649	12,983 Added 22.86%	69,780 $3.04 Million
Q2 2020 Aug 13, 2020	BUY	$34.56 - $44.18 $624,291 - $798,067	18,064 Added 46.64%	56,797 $2.44 Million
Q1 2020 May 14, 2020	BUY	$31.56 - $47.91 $1.22 Million - $1.86 Million	38,733 New	38,733 $1.4 Million

Others Institutions Holding XPH

# of Institutions

Shares Held

2.91M

Call Options Held

13K

Put Options Held

26.1K

View Full List

About SPDR SER TR SPDR S&P PHARMACEU

Ticker XPH
Sector ETFs
Industry ETFs

More about XPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Spdr Ser Tr Spdr S&P Pharmaceu Transaction History